ATOS insider transactions
Atossa Therapeutics Inc. (ATOS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ATOS
- Director Steinhart Richard I was granted 10,000 shares (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Chen Shu-Chih was granted 10,000 shares (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Remmel H. Lawrence was granted 10,000 shares, increasing direct ownership by 1,464% to 10,683 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Finn Jonathan was granted 10,000 shares, increasing direct ownership by 600% to 11,666 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Galli Stephen J was granted 10,000 shares, increasing direct ownership by 166,667% to 10,006 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Cigler Tessa was granted 10,000 shares (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Quay Steven C4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Daniel Mark James4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Amendment: President & CEO Quay Steven C was granted 331,674 shares, increasing direct ownership by 2,386% to 345,572 units (SEC Form 4)4/A - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- President & CEO Quay Steven C was granted 325,203 shares, increasing direct ownership by 2,340% to 339,101 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Daniel Mark James4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 3 filed by new insider Daniel Mark James3 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- President & CEO Quay Steven C bought $9,887 worth of shares (11,239 units at $0.88), increasing direct ownership by 423% to 13,898 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Finn Jonathan4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Steinhart Richard I4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Chen Shu-Chih4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Rees Heather4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Remmel H. Lawrence4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Cigler Tessa4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by President & CEO Quay Steven C4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Galli Stephen J4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Director Remmel H. Lawrence bought $7,000 worth of shares (10,000 units at $0.70), increasing direct ownership by 3,891% to 10,257 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Galli Stephen J4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Steinhart Richard I4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Chen Shu-Chih4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Finn Jonathan4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by SVP, Finance and Accounting Rees Heather4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by President & CEO Quay Steven C4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Cigler Tessa4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Director Remmel H. Lawrence4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Finn Jonathan bought $44,250 worth of shares (25,000 units at $1.77) (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Cigler Tessa4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 3 filed by new insider Cigler Tessa3 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- Weaver Gregory L sold $32,500 worth of shares (50,000 units at $0.65), decreasing direct ownership by 100% to 55 units (SEC Form 4)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Finn Jonathan (Amendment)4/A - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 3 filed by new insider Finn Jonathan3 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Finn Jonathan4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 3 filed by new insider Rees Heather3 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Weaver Gregory L4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Weaver Gregory L4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Weaver Gregory L4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Remmel H. Lawrence4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Steinhart Richard I4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Chen Shu-Chih4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Galli Stephen J4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Steinhart Richard I4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Chen Shu-Chih4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Remmel H. Lawrence4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Galli Stephen J4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Weaver Gregory L4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Quay Steven C4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Guse Kyle4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4: WEAVER GREGORY L exercised 164,581 units of Common Stock at a strike of $2.22, covered exercise/tax liability with 57,084 units of Common Stock and sold $599,833 worth of Common Stock (107,497 units at $5.58)4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Guse Kyle4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Remmel H. Lawrence4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Chen Shu-Chih4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by Steinhart Richard I4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)
- SEC Form 4 filed by WEAVER GREGORY L4 - ATOSSA THERAPEUTICS, INC. (0001488039) (Issuer)